HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
Active, not recruiting · NCT07233070 · Registry updated 2026-06-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke. | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Phase 2 | 2026-06-29 | NCT07233070 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fujian Shengdi Pharmaceutical Co., Ltd. | 31 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Linyi People's Hospital | Linyi | China | 2 |
| The First Affiliated Hospital of Sun Yat-sen University | Guangzhou | China | 1 |